Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients

Penna, Gerson Oliveira; Bührer-Sékula, Samira; Kerr, Lígia Regina Sansigolo; Stefani, Mariane Martins de Araújo; Rodrigues, Laura Cunha; Araújo, Marcelo Grossi de; Ramos, Andrea Machado Coelho; Andrade, Ana Regina Coelho de; Costa, Maurício Barcelos; Rosa, Patricia Sammarco; Gonçalves, Heitor de Sá; Cruz, Rossilene; Barreto, Maurício Lima; Pontes, Maria Araci de Andrade; Penna, Maria Lúcia Fernandes.
Artigo em Inglês | Arca: Repositório institucional da Fiocruz | ID: arc-25529

Documentos relacionados

  1. Results from the clinical trial of uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): decrease in bacteriological index.
  2. Perception of cure among leprosy patients post completion of multi-drug therapy.
  3. Patient profile and treatment satisfaction of Brazilian leprosy patients in a clinical trial of uniform six-month multidrug therapy (U-MDT/CT-BR).
  4. Clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): adverse effects approach.
  5. Accuracy of rapid point-of-care serological tests for leprosy diagnosis: a systematic review and meta-analysis.
  6. Late relapses in leprosy patients in Brazil: 10-year post-trial of uniform multidrug therapy (U-MDT/CT-BR).
  7. Temporal trend, high-risk spatial and spatiotemporal clustering of leprosy indicators in Brazil: A 20-year ecological and population-based study.
  8. Application of a physiotherapeutic protocol associated with photobiomodulation for the treatment of leprosy patients.
  9. Underlying mechanisms of leprosy recurrence in the Western Amazon: a retrospective cohort study.
  10. Clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): adverse effects approach